These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 8690416

  • 1. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
    Honda A, Shefer S, Salen G, Xu G, Batta AK, Tint GS, Honda M, Chen TC, Holick MF.
    Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
    [Abstract] [Full Text] [Related]

  • 2. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A, Salen G, Nguyen LB, Xu G, Tint GS, Batta AK, Shefer S.
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.
    Xu G, Salen G, Shefer S, Ness GC, Chen TS, Zhao Z, Tint GS.
    J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes.
    Shefer S, Salen G, Batta AK, Honda A, Tint GS, Irons M, Elias ER, Chen TC, Holick MF.
    J Clin Invest; 1995 Oct; 96(4):1779-85. PubMed ID: 7560069
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of hepatic lanosterol 14 alpha-demethylase gene expression by dietary cholesterol and cholesterol-lowering agents.
    Ness GC, Gertz KR, Holland RC.
    Arch Biochem Biophys; 2001 Nov 15; 395(2):233-8. PubMed ID: 11697861
    [Abstract] [Full Text] [Related]

  • 14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors unmask cryptic regulatory mechanisms.
    Lopez D, Chambers CM, Ness GC.
    Arch Biochem Biophys; 1997 Jul 01; 343(1):118-22. PubMed ID: 9210653
    [Abstract] [Full Text] [Related]

  • 15. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW.
    Metabolism; 2001 Oct 01; 50(10):1234-41. PubMed ID: 11586500
    [Abstract] [Full Text] [Related]

  • 16. Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome.
    Salen G, Shefer S, Batta AK, Tint GS, Xu G, Honda A.
    J Inherit Metab Dis; 1996 Oct 01; 19(4):391-400. PubMed ID: 8884563
    [Abstract] [Full Text] [Related]

  • 17. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
    Honda A, Salen G, Honda M, Batta AK, Tint GS, Xu G, Chen TS, Tanaka N, Shefer S.
    J Lab Clin Med; 2000 Feb 01; 135(2):174-9. PubMed ID: 10695663
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP, Masters BA, Gregg RE, Durham SK.
    Toxicol Appl Pharmacol; 1997 Jul 01; 145(1):91-8. PubMed ID: 9221828
    [Abstract] [Full Text] [Related]

  • 20. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 01; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.